Avis, N.E., Kaufert, P.A., Lock, M., McKinlay, S.M., and Vass, K. (1993). The evolution of menopausal symptoms. Baillieres Clinical Endocrinology and Metabolism, 7(1), 17-32. Avis, N.E., Stellato, R., Crawford, S., Bromberger, J., Ganz, P., Cain, V. et al. (2001). Is there a menopausal syndrome?
Menopausal status and symptoms across racial/ethnic groups. Social Science and Medicine, 52(3), 345-356.
Baber, R.J., Templeman, C., Morton, T., Kelly, G.E., and West, L. (1999). Randomized placebo-controlled trial of an isoflavone supplement and menopausal symptoms in women. Climacteric, 2(2), 85-92.
Bergmans, M.G., Merkus, J.M., Corbey, R.S., Schellekens, L.A., and Ubachs, J.M. (1987). Effect of Bellergal Retard on climacteric complaints: A double-blind, placebo-controlled study. Maturitas, 9(3), 227-234.
Carpenter, J.S. and Neal, J.G. (2005). Other complementary and alternative medicine modalities: Acupuncture, magnets, reflexology and homeopathy. Paper presented at the NIH State-of-the-Science Conference on Management of Menopause-Related Symptoms, March 21-25, 2005, Bethesda, MD.
Dennerstein, L. (2005). Sexuality. Paper presented at the NIH State-of-the-Science Conference on Management of Menopause-Related Symptoms, March 21-25, 2005, Bethesda, MD.
Dennerstein, L., Dudley, E.C., and Guthrie, JR. (2003). Predictors of declining self-rated health during the transition to menopause. Journal of Psychosomatic Research, 54(2), 147-153.
Dennerstein, L., Randolph, J., Taffe, J., Dudley, E., and Burger, H. (2002). Hormones, mood, sexuality, and the menopausal transition. Fertility and Sterility, 77(Suppl 4), S42-48.
Eisenberg, D.M., Davis, R.B., and Ettner, S.L. (1998). Trends in alternative medicine use in the US, 1990-1997: Results of a follow-up survey. JAMA, 280(18), 1569-1575.
Ettinger, B., Grady, D., Tosteson, A.N., Pressman, A., and Macer, J.L. (2003). Effect of the Women's Health Initiative on women's decisions to discontinue postmenopausal hormone therapy. Obstetrics and Gynecology, 102(6), 1225-1232.
Faure, E.D., Chantre, P., and Mares, P. (2002). Effects of a standardized soy extract on hot flushes: A multicenter, double-blind, randomized, placebo-controlled study. Menopause, 9(5), 329-334.
Freedman, R.R. (2002). Core body temperature variation in symptomatic and asymptomatic postmenopausal women: Brief report. Menopause, 9(6), 399-401.
Freeman, E.W., Sammel, M.D., Liu, L., Gracia, C.R., Nelson, D.B., and Hollander, L. (2004). Hormones and menopausal status as predictors of depression in women in transition to menopause. Archives of General Psychiatry, 61(1), 62-70.
Glickman-Weiss, E.L., Nelson, A.G., Hearon, C.M., Prisby, R., and Caine, N. (1999). Thermal and metabolic responses of women with high fat versus low fat body composition during exposure to 5 and 27 degrees C for 120 min. Aviation Space and Environmental Medicine, 70(3, Pt 1), 284-288.
Gold, E.B., Block, G., Crawford, S., Lachance, L., Fitzgerald, G., Miracle, H., et al. (2004). Lifestyle and demographic factors in relation to vasomotor symptoms: Baseline results from the Study of Women's Health Across the Nation. American Journal of Epidemiology, 159(12), 1189-1199.
Grady, D. (2005). Issues related to discontinuation of menopausal hormone therapy. Paper presented at the NIH State-of-the-Science Conference on Management of Menopause-Related Symptoms.
Han, K.K., Soares, J.M.J., Haidar, M.A., de Lima, G.R., and Baracat, E.C. (2002). Benefits of soy isoflavone therapeutic regimen on menopausal symptoms. Obstetrics and Gynecology, 99(3), 389-394.
Haney, E. (2005). Symptoms during the menopausal transition: Evidence from cohort studies. Paper presented at the NIH State-of-the-Science Conference on Management of Menopause-Related Symptoms, March 21-23, 2005, Bethesda, MD.
Hendrix, S.L., Cochrane, B.B., Nygaard, I.E., Handa, V.L., Barnabei, V.M., Iglesia, C., et al. (2005). Effects of estrogen with and without progestin on urinary incontinence. JAMA, 293(8), 935-948.
Judd, H.L., Judd, G.E., Lucas, W.E., and Yen, S. (1974). Endocrine function of the postmenopausal ovary: Concentration of androgens and estrogens in ovarian and peripheral vein blood. Journal of Clinical Endocrinology and Metabolism, 39(6), 1020-1024.
Knight, D C., Howes, J.B., and Eden, J.A. (1999). The effect of Promensil, an isoflavone extract, on menopausal symptoms. Climacteric, 2(2), 79-84.
Lebherz, T.B. and French, L. (1969). Nonhormonal treatment of the menopausal syndrome. A double-blind evaluation of an autonomic system stabilizer. Obstetrics and Gynecology, 33(6), 795-799.
Li, S. and Holm, K. (2003). Physical activity alone and in combination with hormone replacement therapy on vasomotor symptoms in postmenopausal women. Western Journal of Nursing Research, 25(3), 289-293, 274-288.
Li, S., Holm, K., Gulanick, M., Lanuza, D., and Penckofer, S. (1999). The relationship between physical activity and perimenopause. Health Care for Women International, 20(2), 163-178.
Liu, J.H. (2005). Therapeutic effects of progestins, androgens, and tibolene for menopausal symptoms. Paper presented at the NIH State-of-the-Science Conference on Management of Menopause-Related Symptoms, March 21-25, 2005, Bethesda, MD.
Loprinzi, C.L. (2005). Centrally active, nonhormonal hot flash therapies. Paper presented at the NIH State-of-the-Science Conference on Management of Menopause-Related Symptoms, Bethesda, MD.
Low Dog, T. (2005). Menopause: Review of botanical dietary supplement research. Paper presented at the NIH State-of-the-Science Conference on Management of Menopause-Related Symptoms, Bethesda, MD.
Maartens, L.W., Knottnerus, J.A., and Pop, V.J. (2002). Menopausal transition and increased depressive symptomatology: A community based prospective study. Maturitas, 42(3), 195-200.
Matthews, K.A. and Bromberger, J.T. (2005). Symptoms and health-related quality of life and the menopausal transition. Paper presented at the NIH State-of-the-Science Conference on Management of Menopause-Related Symptoms, Bethesda, MD.
Nikander, E., Kilkkinen, A., Metsa-Heikkila, M., Adlercreutz, H., Pietinen, P., Tiitinen, A., et al. (2003). A randomized placebo-controlled crossover trial with phyto-estrogens in treatment of menopause in breast cancer patients. Obstetrics and Gynecology, 101(6), 1213-1220.
Penotti, M., Fabio, E., Modena, A.B., Rinaldi, M., Omodei, U., and Vigano, P. (2003). Effect of soy-derived isoflavones on hot flushes, endometrial thickness, and the pulsatility index of the uterine and cerebral arteries. Fertility and Sterility, 79(5), 1112-1117.
Pittler, M.H. and Ernst, E. (2002). Kava extract for treating anxiety. [Update of Cochrane Database Syst Rev. 2002;(2):CD00383; PMID:12076477.] Cochrane Database of Systematic Reviews, 1(CD003383).
Rossouw, J.E., Anderson, G.L., Prentice, R.L., LaCroix, A.Z., Kooperberg, C., Stefanick, M.L., et al. (2002). Writing Group for the Women's Health Initiative Investigators. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: Principal results from the Women's Health Initiative randomized controlled trial. JAMA, 288(3), 321-333.
Sherwin, B.B. (1998). Use of combined estrogen-androgen preparations in the postmenopause: Evidence from clinical studies. International Journal of Fertility and Women's Medicine, 43(2), 98-103.
Sherwin, B.B. (2002). Randomized clinical trials of combined estrogen-androgen preparations: Effects on sexual functioning. Fertility and Sterility, 77(Suppl 4), S49-S54.
Shumaker, S.A., C., L., Kuller, L., Rapp, S.R., Thal, L., Lane, D.S., et al. (2004). Women's Health Initiative Memory Study. Conjugated equine estrogens and incidence of probable dementia and mild cognitive impairment in post-menopausal women: Women's Health Initiative Memory Study. JAMA, 291(24), 2947-2958.
Simon, J., Klaiber, E., Wiita, B., Bowen, A., and Yang, H.M. (1999). Differential effects of estrogen-androgen and estrogen-only therapy on vasomotor symptoms, gonadotropin secretion, and endogenous androgen bioavailability in post-menopausal women. Menopause, 6(2), 138-146.
Sternfeld, B., Quesenberry, C.P.J., and Husson, G. (1999). Habitual physical activity and menopausal symptoms: A case-control study. Journal of Women's Health, 8(1), 115-123.
Tice, J.A., Ettinger, B., Ensrud, K., Wallace, R., Blackwell, T., and Cummings, S.R. (2003). Phytoestrogen supplements for the treatment of hot flashes: The Isoflavone Clover Extract (ICE) Study: A randomized controlled trial. JAMA, 290(2), 207-214.
van de Weijer, P.H. and Barentsen, R. (2002). Isoflavones from red clover (Promensil) significantly reduce menopausal hot flash symptoms compared with placebo. Maturitas, 42(3), 187-193.
Van Voorhis, B.J. (2005). Perimenopause: Urogenital and bleeding issues. Paper presented at the NIH State-of-the-Science Conference on Management of Menopause-Related Symptoms, Bethesda, MD.
Whiteman, M.K., Staropoli, C.A., Langenberg, P.W., McCarter, R.J., Kjerulff, K.H., and Flaws, J.A. (2003). Smoking, body mass, and hot flashes in midlife women. Obstetrics and Gynecology, 101(2), 264-272.
This page intentionally left blank
Was this article helpful?
Do You Suffer From The Common Cold, Hair Loss, Erectile Dysfunction, Cancer, Arthritis, Allergies, Diabetes, Depression, High Blood PressureCholesterol, Or Hemorrhoids? With health care on the rise, many people are looking for natural alternatives to the costly medications we currently rely on.